MIRM Logo

Mirum Pharmaceuticals, Inc. (MIRM) 

NASDAQ
Market Cap
$1.55B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
71 of 809
Rank in Industry
56 of 445

Largest Insider Buys in Sector

MIRM Stock Price History Chart

MIRM Stock Performance

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.

Insider Activity of Mirum Pharmaceuticals, Inc.

Over the last 12 months, insiders at Mirum Pharmaceuticals, Inc. have bought $4.62M and sold $2.71M worth of Mirum Pharmaceuticals, Inc. stock.

On average, over the past 5 years, insiders at Mirum Pharmaceuticals, Inc. have bought $56.09M and sold $5.18M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Heron Patrick J () — $33.78M. BJERKHOLT ERIC (Chief Financial Officer) — $1.19M.

The last purchase of 2,000 shares for transaction amount of $49,600 was made by BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) on 2024‑03‑27.

List of Insider Buy and Sell Transactions, Mirum Pharmaceuticals, Inc.

2024-06-24SaleVig PamelaCHIEF SCIENTIFIC OFFICER
30,559
0.0633%
$34.00$1.04M-4.91%
2024-06-05SaleRamasastry Sairadirector
5,000
0.0104%
$25.68$128,400+2.66%
2024-03-27PurchaseBJERKHOLT ERICCHIEF FINANCIAL OFFICER
2,000
0.0042%
$24.80$49,600+0.80%
2024-03-25SaleRadovich PeterPRESIDENT AND COO
4,303
0.0091%
$25.80$111,017-3.59%
2024-03-18PurchaseBJERKHOLT ERICCHIEF FINANCIAL OFFICER
2,000
0.0043%
$25.80$51,600-2.57%
2024-02-02SaleLongpre LaraCHIEF DEVELOPMENT OFFICER
847
0.0018%
$26.19$22,184-2.06%
2024-02-02SalePeetz ChristopherCHIEF EXECUTIVE OFFICER
6,013
0.0127%
$26.19$157,491-2.06%
2024-02-02SaleRadovich PeterPRESIDENT AND COO
1,790
0.0038%
$26.19$46,883-2.06%
2024-02-02SaleVig PamelaCHIEF SCIENTIFIC OFFICER
1,214
0.0026%
$26.19$31,797-2.06%
2024-02-02SaleHowe JolandaSVP, GLOBAL CONTROLLER
735
0.0015%
$26.19$19,251-2.06%
2024-01-08SalePeetz ChristopherPRESIDENT AND CEO
5,209
0.011%
$28.03$146,033-7.93%
2024-01-08SaleLongpre LaraCHIEF DEVELOPMENT OFFICER
1,019
0.0022%
$28.04$28,568-7.93%
2024-01-08SaleRadovich PeterCHIEF OPERATING OFFICER
1,408
0.003%
$28.03$39,473-7.93%
2024-01-08SaleVig PamelaHEAD OF RESEARCH & DEVELOPMENT
1,408
0.003%
$28.03$39,472-7.93%
2024-01-08SaleHowe JolandaSVP, GLOBAL CONTROLLER
528
0.0011%
$28.04$14,803-7.93%
2023-12-05SaleHowe JolandaSVP, Global Controller
2,500
0.0053%
$32.40$81,000-18.94%
2023-09-14SaleGREY MICHAEL Gdirector
14,216
0.0367%
$32.00$454,912-13.60%
2023-09-13PurchaseHeron Patrick Jdirector
2,625
0.0068%
$31.02$81,425-6.64%
2023-09-12PurchaseHeron Patrick Jdirector
3,750
0.0096%
$30.60$114,764-9.92%
2023-09-11PurchaseHeron Patrick Jdirector
4,687
0.0122%
$30.30$142,027-8.02%

Insider Historical Profitability

29.92%
Heron Patrick Jdirector
159053
0.3412%
$32.8650+5.09%
Longpre LaraCHIEF DEVELOPMENT OFFICER
104407
0.224%
$32.8615
Peetz ChristopherCHIEF EXECUTIVE OFFICER
104112
0.2233%
$32.8645+41.16%
Radovich PeterPRESIDENT AND COO
29013
0.0744%
$32.8606
Vig PamelaCHIEF SCIENTIFIC OFFICER
27406
0.0615%
$32.8616+53.04%
BJERKHOLT ERICChief Financial Officer
14000
0.0215%
$32.8630
Howe JolandaSVP, GLOBAL CONTROLLER
1759
0.0038%
$32.8605
GREY MICHAEL Gdirector
0
0%
$32.8603
Ramasastry Sairadirector
0
0%
$32.8601
Chang Carmen10 percent owner
4186243
8.9806%
$32.8610+5.09%
MOTT DAVID M10 percent owner
4186243
8.9806%
$32.8610+5.09%
Behbahani Ali10 percent owner
4186243
8.9806%
$32.8610+5.09%
BARRIS PETER J10 percent owner
4186243
8.9806%
$32.8610+5.09%
BASKETT FOREST10 percent owner
4186243
8.9806%
$32.8610+5.09%
MAKOWER JOSHUA10 percent owner
4186243
8.9806%
$32.8610+5.09%
SANDELL SCOTT D10 percent owner
4186243
8.9806%
$32.8610+5.09%
Sonsini Peter W.10 percent owner
4186243
8.9806%
$32.8610+5.09%
Makhzoumi Mohamad10 percent owner
4186243
8.9806%
$32.8610+5.09%
Walker Paul Edward10 percent owner
4186243
8.9806%
$32.8610+5.09%
Florence Anthony A. Jr.10 percent owner
4186243
8.9806%
$32.8610+5.09%
New Enterprise Associates 16, L.P.10 percent owner
4186243
8.9806%
$32.8610+5.09%
Frazier Life Sciences IX, L.P.10 percent owner
3566912
7.652%
$32.8610+5.09%
Novo Holdings A/S10 percent owner
2445147
5.2455%
$32.8610+5.09%
O'Donnell Nialldirector
1621118
3.4777%
$32.8613+5.09%
Deerfield Healthcare Innovations Fund, L.P.
1540190
3.3041%
$32.8601
Tucker Edwin JonathanChief Medical Officer
45768
0.0982%
$32.8621+71.87%
Clements IanChief Financial Officer
18561
0.0398%
$32.8641+42.68%
Brege Lauradirector
10000
0.0215%
$32.8610+63.65%
Fischer Laurentdirector
6750
0.0145%
$32.8650+66.98%
Flynn James E10 percent owner
0
0%
$32.8614+5.09%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Frazier Life Sciences Management L P$163.16M13.786.5M0%+$08.38
Bvf Inc Il$109.78M9.274.37M0%+$00.81
Eventide Asset Management$82.91M73.3M+23.91%+$16M1.31
State Street$70.9M5.992.82M+62.7%+$27.32M<0.01
Janus Henderson$69.47M5.872.77M+34.16%+$17.69M0.04
BlackRock$61.6M5.22.45M-0.39%-$238,062.24<0.01
Cadian Capital Management LP$57.59M4.862.29M+18.48%+$8.98M2.05
The Vanguard Group$55.56M4.692.21M-10.68%-$6.65M<0.01
ROCK SPRINGS CAPITAL MANAGEMENT, LP$46.64M3.941.86M+0.28%+$128,112.001.19
T. Rowe Price$40.13M3.391.6M+37.16%+$10.87M0.01
Novo Holdings A/S$37.68M3.181.5M0%+$02.63
Citadel Advisors LLC$34.98M2.951.39M-3.49%-$1.26M0.02
Tang Capital Management, LLC$29.82M2.521.19M+4.4%+$1.26M0.12
Avidity Partners Management Lp$28.71M2.421.14M0%+$01.04
Franklin Templeton Investments$23.65M2941,374+3.1%+$711,046.720.01
Goldman Sachs$17.59M1.49700,116+53.43%+$6.12M<0.01
Geode Capital Management$17.52M1.48697,139+2.34%+$400,960.62<0.01
William Blair Investment Management$15.76M1.33627,272+0.88%+$138,009.280.04
Polar Capital$15.7M1.33625,0000%+$00.09
AXA$14.92M1.26593,786+0.01%+$1,833.760.05
Millennium Management LLC$13.56M1.15539,666+140.52%+$7.92M0.01
Prosight Management Lp$11.68M0.99465,000+58.54%+$4.31M3.25
Boone Capital Management Llc$11.35M0.96451,898-7.8%-$960,613.942.3
Citigroup$9.32M0.79371,051+335.35%+$7.18M0.01
Morgan Stanley$8.91M0.75354,588+44.91%+$2.76M<0.01
Bank of America$7.85M0.66312,613+107.27%+$4.06M<0.01
Nuveen$7.82M0.66311,185-33.84%-$4M<0.01
Northern Trust$7.06M0.6281,079-2.42%-$174,734.71<0.01
Barclays$6.9M0.58274,866+175.08%+$4.39M<0.01
Charles Schwab$6.82M0.58271,654+1.86%+$124,921.75<0.01
Rafferty Asset Management Llc$6.69M0.57266,262+104.27%+$3.41M0.02
ClearBridge Investments$6.62M0.56263,584-0.19%-$12,886.560.01
Penn Capital Management Co Inc$6.18M0.52245,696-0.01%-$804.900.24
Elequin Securities Llc$6.18M0.52245,696+264,089.25%+$6.18M0.24
Ardsley Advisory Partners$6.15M0.52245,000+8.89%+$502,400.000.89
Deutsche Bank$6.13M0.52244,151+42.34%+$1.82M<0.01
Qube Research & Technologies$6.07M0.51241,498+93.75%+$2.94M0.01
Woodline Partners LP$5.86M0.5233,267-7.89%-$502,299.520.06
Ensign Peak Advisors Inc$5.59M0.47222,6140%+$00.01
Rice Hall James & Associates, LLC$5.4M0.46214,887+401.6%+$4.32M0.33
Altium Capital Management Lp$5.22M0.44208,000New+$5.22M2.43
Two Sigma Advisers LP$4.95M0.42197,000-41.42%-$3.5M0.01
New York State Common Retirement Fund$4.94M0.42196,679-11.75%-$657,823.590.01
Baker Bros Advisors LP$4.78M0.4190,4760%+$00.06
Silvercrest Asset Management Group Inc$4.09M0.35162,817+64.55%+$1.6M0.03
Adage Capital Partners Gp L L C$4.02M0.34160,000-72.17%-$10.42M0.01
Affinity Asset Advisors$4.02M0.34160,000+220%+$2.76M0.71
UBS$3.94M0.33156,911+32.37%+$963,854.57<0.01
Two Sigma$3.9M0.33155,353-20.79%-$1.02M0.01
Nicholas Investment Partners, L.P.$3.79M0.32151,002-62.14%-$6.23M0.43